Weaker Dollar Aids Drug-Makers' Sales

Major U.S. drug makers including Pfizer Inc. and Eli Lilly & Co. are flying against some strong headwinds: patent expirations, drug pipeline setbacks, price cuts imposed by European national health programs, and higher costs from the U.S. health-care...